The approval represents a win in what’s been a difficult regulatory environment of late for vaccine makers, and could boost uptake of a shot that’s posted flattening sales after an initially strong ...

The Modelling-Informed Medicine Centre will create computer models or digital twins of organs and diseases to better understand how diseases of the lungs, liver, and kidneys progress, to discover and ...

In A Nutshell Researchers have launched a free, publicly accessible 3D atlas of real human organs that lets anyone zoom from whole-organ views down to near-cellular detail in a web browser. The scans ...

Great. Thank you for coming, everybody. I'm James Gordon, Barclays European pharma and biotech analyst. And today, I've got the pleasure of hosting a fireside with GSK. So we're going to hear from GSK ...

GSK's new CEO, Luke Miels, focuses on enhancing sales growth and accelerating drug development. Despite imminent patent expiries for HIV drugs, Miels assures stable capital allocation strategies and ...

LONDON, Feb 4 (Reuters) - GSK's new CEO Luke ‌Miels said on Wednesday that the drugmaker will ‌aim to lift sales growth and speed up work on new medicines in its next phase of growth through a sharper ...

Multiple Solid Tumor Settings to Be Pursued with Clinical Trials Expected to Start in Mid-2026 MIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (SMMT) today announced it has entered into a clinical ...

GSK & Fleming Initiative launch six AI-powered “Grand Challenges” to outpace antimicrobial resistance, targeting deadly drug-resistant infections & AMR One in six laboratory-confirmed bacterial ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics through its boron chemistry platform, today announced a collaboration agreement with the ...

GSK plc (NYSE:GSK) Q3 2025 Earnings Call Transcript October 29, 2025 GSK plc beats earnings expectations. Reported EPS is $1.48, expectations were $1.26. Operator: Ladies and gentlemen, a very warm ...